6550--FY25: CEPHEID Molecular Platforms Reagents B+4

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 8 has issued a Special Notice announcing its intent to award a sole source contract to Cepheid, located in Sunnyvale, California, for molecular platform reagents. The procurement will support the Orlando Healthcare System, situated at 13800 Veterans Way in Orlando, Florida. This procurement is being conducted under 41 USC 3304(a)(1) as implemented by Federal Acquisition Regulation 6.302-1, with a North American Industry Classification System code of 334516 and a small business administrative size standard of 1,000 employees. The current Federal Acquisition Circular is 2025-03, dated 01/17/2025, and the solicitation number is 36C24825Q0311. The Special Notice represents the government's sole communication regarding its intent to solicit and award the contract to a single source.

Potential contractors who believe they possess the technical capability to meet the government's specific requirements are invited to submit a comprehensive technical package demonstrating their ability to fulfill the contract needs. The submission deadline is January 30, 2024, at 1:00 PM Eastern Standard Time, with all responses to be sent directly to Contracting Officer Benjamin Amato via email at benjamin.amato@va.gov. The government emphasizes that it will not compensate vendors for submitted information, and any responses received will be considered for potential future procurement opportunities. Eligible vendors should focus on providing clear and convincing evidence of their technical capabilities specific to the required molecular platform reagents. The Product Service Code for this procurement is 6550, which corresponds to In Vitro Diagnostic Substances, Reagents, Test Kits and Sets. Contractors should carefully review the requirements and ensure their technical package comprehensively addresses the government's specific needs for the Cepheid molecular platforms reagents.